Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2737 - 2744 of 12085 results
New Draft Policy Will Create Obstacles For SEP Owners
December 22, 2021| News
To Retain Minority Attys, Aim For 'Psychological Safety'
December 22, 2021| News
The Road Less Travelled: Why Arbitration is Increasingly Attractive for Resolving IP Disputes
December 22, 2021| News
New Year, New Laws: An Overview of New Laws Impacting New York Nursing Homes in January 2022
December 21, 2021| Blog| Viewpoint
Department of Labor Rescinds Prior Regulation that Dramatically Increased Prevailing Wages
December 21, 2021| Alert| Viewpoint
Is COVID-19 a Disability? Answer: Sometimes
December 17, 2021| Blog| Viewpoint
New York City Releases Private Employer Vaccine Executive Order
December 16, 2021| Blog| Viewpoint
The Shrinking Scope of Confidentiality: California Extends Confidentiality Ban to All FEHA Protected Classes
December 15, 2021| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|